|
FDA Addresses Zolgensma Gene Therapy Data Manipulation
|
 The agency said the gene therapy should remain on the market while it assesses the situation and does not impact their evaluation of data from the human clinical trials. |
|
Read more
|
|
|
| Central Issues in Stroke Care |
 The International Congress on the Future of Neurology will take place this Fall in New York City, convening experts in neurology to discuss the latest data and best practices to better inform clinical decision-making. |
|
Read more
|
